同花顺美股讯 1月7日William Blair将inari medical评级从跑赢大盘下调评级为市场持平。INARI Medical于10月28日发布2024年三季报,公司截至2024年9月30日,营业收入4.42亿美元,同比22.37%,净利润-7391.70万美元,基本每股收益-1.27美元。Inari Medical, Inc.于2011年7月在特拉华州成立,总部位于加利福尼亚州尔湾。该...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.